| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $7.26B | +16.8% |
| R&D Expense | $2.46B | +8.5% |
| SG&A Expense | $702.0M | +16.2% |
| Operating Income | $183.0M | +182.4% |
| Interest Expense | $114.0M | +11.4% |
| Pre-tax Income | $356.0M | +236.9% |
| Income Tax | -$1.02B | -1059.7% |
| Net Income | $1.38B | +476.6% |
| EPS (Basic) | $5.28 |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.01B | +6.7% |
| Short-term Investments | $5.80B | +37.0% |
| Accounts Receivable | $1.64B | +4.4% |
| Current Assets | $9.94B | +22.6% |
| Total Assets | $16.45B | +22.0% |
| Current Liabilities | $5.05B | +9.2% |
| Long-term Debt | $2.98B | +0.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.15B | +29.7% |
| Investing Cash Flow | -$1.75B | +30.1% |
| Financing Cash Flow | -$268.0M | -122.3% |
| +466.7% |
| EPS (Diluted) | $5.21 | +461.8% |
| Total Liabilities |
| $8.37B |
| +5.9% |
| Stockholders' Equity | $8.08B | +44.7% |